Newborn !
Posted on
The FAIMS interface has just been installed on our new Orbitrap Exploris 480. This new MS instrument will enlarge our analytical capabilities.
Author: EDyP Lab
Open PhD position
Posted on
Delphine Pflieger is seeking a motivated student to perform a PhD starting in October 2021. Briefly, the project aims at better understanding the molecular dysfunctions at stake in the rare neurodegenerative disease called Huntington’s disease, which results in motor, cognitive and psychiatric symptoms. More specifically, we want to decipher how perturbations of histone modifications lead […]
Offre d’emploi
Posted on
Pour participer à son activité de R&D et de service à la communauté, l’équipe EDyP, localisée à Grenoble, recherche un/une ingénieur(e) d’Etudes en analyses protéomiques basées sur la spectrométrie de masse. Au sein de l’équipe EDyP (Exploration de la Dynamique des Protéomes, edyp.fr), vous mettrez en oeuvre un ensemble de techniques et méthodes analytiques et […]
PepS Publication
Posted on
We are very proud to announce the publication of the PepS microfluidic device in Analytical Chemistry
Publications 2021
Posted on
Proline Publication
Posted on
We are pleased and very proud to announce the publication of Proline in Bioinformatics. Feel free to try the software by downloading the zero installation version.
ProteoRE version 2.1 is released
Posted onWe are pleased to announce the release of ProteoRE 2.1, a user-oriented Galaxy-based instance, for the functional interpretation and exploration of proteomics data for biomedical research; This version now comprises 20 tools organized in 4 sections (data manipulation and visualization; add features/annotation; functional analysis; pathways analysis. All data sources have been updated. Three new tools […]
Publications 2020
Posted on
Hepatitis
Posted on
Identifying HBc nuclear regulatory functions Despite the existence of a preventive vaccine, chronic infections with Hepatitis B virus (HBV) remain a major health problem worldwide, and represent the first cause of liver cancer. Current clinically accepted antivirals treatments generally lead to a significant reduction of viremia in the blood of patients. However, the liver viral […]
Francisella tularensis
Posted on
Understanding antibiotic resistance of Francisella ssp Francisella tularensis is the causative agent in tularemia for which the high prevalence of treatment failure and relapse is a major concern. Using MS-based proteomics, we explore the proteomes of different Francisella strains to identify proteins that may contribute to reduced antibiotic susceptibility. Collaborators Patricia Renesto, Experimental Recombinant Therapy […]